Day-to-day research results on the COVID-19 situation in hospitals, based on our own COVID-19 registry.Read more
Let our team help you turn your idea into a successful study.
Regardless of how much you have already developed your idea or whether it is still in the initial planning stages, we sit down with you and work together to develop your idea. You contribute your expertise and we use our experience to guide you.
We work together with you to turn your idea into the concept for your study. In collaboration with you, we define the scientific, methodical and statistic requirements for the study protocol and plan a schedule for the study that can be reliably implemented.
We work together to establish criteria for patient safety. We discuss what data is necessary for your study and develop the right case report form for you with our EBogen software. This means that you obtain clear and valid data for your research.
We determine the expected duration of the study according to your requirements. We work with the study centres to establish the realistic number of patients you can expect for your study.
Using the Monte Carlo simulation, we use a number of different possible study scenarios to calculate the number of patients that can be reliably expected over the course of your study on a statistical basis.
You receive a model that illustrates patient inclusion and also takes into account the deviations that can occur in any study.
Budget and financing
We will use your concept as the basis for creating a transparent and viable time and cost schedule that can be used to win over potential donors. If you wish, we would be happy to help you with this.
Submission to ethics committees
Medical Devices Act (MPG) Sections 20-23a
MPG Section 23b
Post Authorisation Safety Study
Federal Institute for Drugs and Medical Devices (BfArM) & Paul Ehrlich Institute (PEI)
Comparative studies of strategies
MPA (Medicinal Products Act)
Federal Office for Radiation Protection (Bundesamt für Strahlenschutz)
Presentation of the second evaluation of the COVID-19 registry for Rhineland-Palatinate by Dr. Anselm K. Gitt, board of directors of Foundation Institute for Myocardial Infarction Research in and study director of the COVID-19 registry...Read more
Dr Anselm K. Gitt, board member of the IHF, reports on his current research results on the COVID-19 situation in hospitals in a video conference hosted by Torbjörn Kartes, member of the German BundestagRead more